Waiting for the 1/2 year before updating my DCF valuations
How rich we get all depends on how Trilogy Skincare/ Ecoya (to a lesser extent) perform. CS will be a steady earner and the icing on the cake
Below is my old chart showing my forecast Trilogy/Ecoya sales under different growth scenarios.
The guidance for F17 is below the Conservative- Low Growth forecast
I am winding back my overall expectations (maybe sucked in by the hype) and am starting to think the Conservative case is going to play out. The Base Case is now the growth story. The High Growth case is just pie in the sky stuff (even though some brokers are pretty close to my numbers)
As such $3.14 is a fair valuation and if you believe the story $4.44 is it (current value, not a target)
Trading accordingly
Bookmarks